AR002727A1 - El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. - Google Patents

El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.

Info

Publication number
AR002727A1
AR002727A1 ARP960101944A AR10194496A AR002727A1 AR 002727 A1 AR002727 A1 AR 002727A1 AR P960101944 A ARP960101944 A AR P960101944A AR 10194496 A AR10194496 A AR 10194496A AR 002727 A1 AR002727 A1 AR 002727A1
Authority
AR
Argentina
Prior art keywords
ridogrel
preparing
manufacture
pharmaceutical composition
treatment
Prior art date
Application number
ARP960101944A
Other languages
English (en)
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR002727A1 publication Critical patent/AR002727A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
ARP960101944A 1995-03-28 1996-03-27 El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. AR002727A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28

Publications (1)

Publication Number Publication Date
AR002727A1 true AR002727A1 (es) 1998-04-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101944A AR002727A1 (es) 1995-03-28 1996-03-27 El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.

Country Status (10)

Country Link
EP (1) EP0817631A2 (fr)
JP (1) JPH10511097A (fr)
AR (1) AR002727A1 (fr)
AU (1) AU5397496A (fr)
CA (1) CA2215160A1 (fr)
HU (1) HUP9900309A3 (fr)
IL (1) IL117670A (fr)
NO (1) NO974486D0 (fr)
WO (1) WO1996030016A2 (fr)
ZA (1) ZA962461B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
EP1370244A1 (fr) * 2001-03-12 2003-12-17 Novo Nordisk A/S Nouveaux comprimes et gelules et procede de preparation correspondant
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
PT2396081T (pt) 2009-02-16 2017-07-11 Nogra Pharma Ltd Compostos alquilamido e suas utilizações
CA2864059C (fr) 2012-02-09 2020-04-28 Nogra Pharma Limited Methodes de traitement de la fibrose
BR112014026160A2 (pt) 2012-04-18 2017-07-18 Nogra Pharma Ltd métodos para tratar intolerância à lactose
WO2017046343A1 (fr) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions pour une administration par voie rectale dans le traitement de la colite ulcéreuse et leurs procédés d'utilisation
EA202192207A1 (ru) 2019-02-08 2021-10-27 Ногра Фарма Лимитед Способ получения 3-(4'-аминофенил)-2-метоксипропионовой кислоты и ее аналогов и промежуточных соединений

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
JPH10511097A (ja) 1998-10-27
EP0817631A2 (fr) 1998-01-14
ZA962461B (en) 1997-09-29
WO1996030016A2 (fr) 1996-10-03
IL117670A (en) 2000-02-29
HUP9900309A2 (hu) 1999-05-28
CA2215160A1 (fr) 1996-10-03
WO1996030016A3 (fr) 1997-01-30
NO974486L (no) 1997-09-29
NO974486D0 (no) 1997-09-29
AU5397496A (en) 1996-10-16
HUP9900309A3 (en) 1999-11-29
IL117670A0 (en) 1996-07-23
MX9707394A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
CA2237306C (fr) Supports d'administration pour medicaments analgesiques, anti-inflammatoires et antipyretiques contenant de l'oxyde nitreux et compositions pharmaceutiques contenant ces supports et ces medicaments
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
CA2066403A1 (fr) Forme pharmaceutique permettant l'absorption a travers la muqueuse
RU94046316A (ru) Применение высокоэффективных фосфонатов при изготовлении лекарственных средств для лечения остеопороза
MX171191B (es) Composiciones farmaceuticas de glipizida
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
MX9400287A (es) Procedimiento para la preparacion de un medicamento util para el tratamiento de la enfermedad de parkinson
ES2173641T3 (es) Composicion de derivados opiaceos para la fabricacion de medicamentos.
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
KR970025615A (ko) 암 전이 억제제
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
AR002727A1 (es) El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
KR0178762B1 (ko) 특정 인돌 유도체의 신규 의약적 용도 및 그를 함유하는 제약 조성물
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
BE1002256A3 (fr) Medicaments.
NZ207411A (en) Pharmaceutical compositions containing paracetamol and tizanidine
JPS59116219A (ja) 中枢鎮痛剤とビタミンｂ１２又はその誘導体との組合せを活性成分として含む新規な鎮痛剤組成物
KR910007528A (ko) 벤조디아제핀 및 페닐피릴케톤 유도체의 용도
GB2135884A (en) Analgesic preparations containing tizanidine and paracetamol
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)